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2D-DIGE analysis coupled with mass spectrometry is a global,
without a priori, comparative proteomic approach particularly
suited to identify and quantify enzymes isoforms and structural
proteins, thus making it an efﬁcient tool for the characterization of
the changes in cell phenotypes that occur in physiological and
pathological conditions. In this data article in support of the
research article entitled “Metabolic reprogramming in trans-
formed mouse cortical astrocytes: a proteomic study” [1] we
illustrate the changes in protein proﬁle that occur during the
metabolic reprogramming undergone by cultured mouse astro-
cytes in a model of in-vitro cancerous transformation [2].
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A. Bentaib et al. / Data in Brief 2 (2015) 1–52Speciﬁcations tableSubject area BiologyMore speciﬁc subject area Cancer biology, Neurobiology
Type of data Table, ﬁgures
How data was acquired Fluorescence scanning of bi-dimensional electrophoretic
separations of pre-labeled protein samples, using a
Typhoon 9400 scanner.
Mass spectrometry of peptides generated from proteins in
2D gel plugs, using an UltraFlex II spectrometer (Brüker
Daltonics).Data format Analyzed using DeCyder 7.0 program
Experimental factors Proteins extracted from treated and control cultures in a
detergent and urea containing buffer, then labeled with
CyDyes.Experimental features 2D electrophoresis (1st dimension pH 3–10 gradient; 2nd
dimension 12.5% PAGE). Spot picking with EtanDalt
Spotpicker. Trypsin digestion of proteins and MALDI-TOF/
TOF analysis of the peptides.Data source location N/A
Data accessibility Data is provided in Supplementary materials directly with
this article.Value of the data Quantitative proteomics study exploring the changes in cellular protein abundance that result from
metabolic reprogramming following astrocyte transformation. Multiple changes occur with similar amplitude for enzymes catalyzing successive steps in
canonical metabolic pathways. Illustration of the power of 2D-DIGE to reveal (and quantify) changes in abundance of multiple
isoforms of enzymes and cellular proteins.1. Data, experimental design, materials and methods
Using the 2D-DIGE approach we have obtained relevant information on the changes in abundance
of most enzymes implicated in major canonical metabolic pathways [1]. Supplementary Table 1 lists
all the identiﬁed proteins whose abundance differs by at least 1.5-fold (po0.05, student t-test)
between normal astrocytes (NA) and transformed astrocytes (TA).
Our results suggest that transformation causes major losses of astrocyte-speciﬁc proteins and
functions and the acquisition of metabolic adaptations that favor intermediate metabolites production
for increased macromolecule biosynthesis. We also observe a loss of some enzymes implicated in the
oxidative stress defense. This is illustrated in Supplementary materials showing zoomed-in 2D gels
regions where the spots containing the proteins/enzymes that underwent these changes (e.g.
Pyruvate kinase, Lactate dehydrogenase, Glutamate dehydrogenase, Glutamine synthetase, Transal-
dolase, Peroxiredoxin 1 and 6, Glutathione S-transferase Mu1…) are visible, together with a graphical
representation of the quantitative data.
1.1. Cell culture preparation
Cultures of mouse normal astrocytes were prepared from cortices of 1-to-2-day-old C57Bl6/J mice
according to protocols described by Sharif in 2007 [3] and Prevot in 2005 [4] with slight adaptations.
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calf serum (FCS) (Lonza, BioWhittakers, Belgium). Medium was changed every 2 days following
washes with ice-cold phosphate-buffered saline (PBS, pH 7.4). When conﬂuence was reached, cultures
were shaken overnight (250 rpm), trypsinized and seeded in 8 cm dishes at a density of 50,000 cell/
cm2. When conﬂuence was reached again, the cells were maintained in serum-free MEM medium for
48 h, rinsed twice in PBS, and either extracted for protein sample preparation or frozen until further
use. Glial ﬁbrillary acidic protein (GFAP)-immunoreactive astrocytes accounted for 91–96% of the cells
in the NA cultures, the remaining 4–9% of cells being CD11b receptor-immunoreactive microglia [3].
The transformed astrocytes are obtained from normal mouse astrocytes that had undergone a
treatment with TGF alpha allowing them to dedifferentiate into “neural progenitor-like cells” followed
by gamma irradiation causing their in vitro transformation [2]. Transformed astrocytes are cultured in
medium composed of a mixture of DMEM and F12 medium (Invitrogen, France), containing 0.6%
glucose, 2 mM glutamine, 13 mM sodium bicarbonate, 5 mM N-2-hydroxyethylpiperazine-N'-2-
ethanesulfonic acid (HEPES) buffer, 5 IU/ml penicillin and 5 mg/ml streptomycin, and the B27
complement (Gibco, ref 12587-010). This medium was renewed once a week. Due to the selection
process and growth conditions, all the cells generated from the irradiated cultures were transformed
astrocytes.
1.2. Sample preparation for comparative proteomic studies
NA and TA were collected in lysis buffer (7 M urea, 2 M thiourea, 30 mM Tris, pH 8.5 (all from GE
Healthcare) and 2% (w/v) ASB-14 (Sigma)) and sonicated for 10 min. After removal of the insoluble
material by centrifugation (20.000g), each sample was precipitated using the 2D Clean-up kit (GE
Healthcare) in order to remove salts and low molecular weight contaminants that interfere with
CyDye-labeling and protein electrophoresis. Protein pellets were resuspended in adequate volume of
lysis buffer and the pH was adjusted to 8.5 with 100 mM NaOH for efﬁcient CyDye labeling.
Protein concentration was evaluated with the RC/DC Protein Assay (Bio-Rad Laboratories).
1.3. 2D-DIGE
2D-DIGE comparative proteomic analysis was performed using a set of 4 independent cultures in
each experimental condition (NA and TA).
For analytical gels, 25 mg of each biological replicate were labeled separately with 200 pmol of
CyDye (Cy3, Cy5; GE Healthcare) with dye-swapping to minimize dye-speciﬁc labeling effect,
vortexed, and incubated 30 min in the dark. At the same time, a pool of equal amounts of proteins
from all the biological replicates was labeled with Cy2 for use as an internal standard. After 30 min in
the dark, the reaction was stopped with 10 mM lysine. Multiplexing was achieved by pooling 25 mg of
Cy3- and Cy5-labeled samples together with 25 mg of Cy2-labeled internal standard, used for
matching and normalization between gels, and the volume of the combined labeled samples was
adjusted to 450 mL with standard rehydration buffer (7 M urea, 2 M thiourea, 2% w/v ASB 14, 25 mM
DTT, and 0.6% v/v pH 3–10 NL IPG buffer (GE Healthcare)). The mixed CyDye-labeled samples were
used to rehydrate 24 cm IPG strips (pH 3–10 NL, GE Healthcare) for 12 h at 20 1C. Isoelectric focusing
(IEF) was carried out at 500 V for 1 h, followed by two successive 3 h gradients (1st gradient, 500–
1000 V, 2nd gradient 1000–8000 V), and constant setting at 8000 V for 70 kVh at 20 1C. The
maximum current setting was 50 mA per strip in an IPGphor isoelectric focusing unit (GE Healthcare).
Prior to second dimension separation, the IPG strips were incubated 15 min at room temperature
(RT) in equilibration buffer (30% glycerol (v/v), 1.6% SDS (w/v), 6 M urea, 50 mM Tris–HCl pH 8.8)
containing 1% DTT and then for 15 min in the same solution containing 5% iodoacetamide. They were
then sealed with 0.5% agarose in SDS running buffer, and placed on top of 12.5% w/v polyacrylamide
gels. The second dimension electrophoresis was performed overnight at 30 1C in an Ettan Dalt-6
system (GE Healthcare) at a 50 V constant voltage. Each gel was ﬁnally scanned with the Typhoon
9400 scanner (GE Healthcare) at the emission wavelengths corresponding to each CyDye, namely
520 nm (Cy2), 580 nm (Cy3) and 670 nm (Cy5).
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Images (n¼4 for each experimental condition) were analyzed with the DeCyder 7.0 software (GE
Healthcare) according to the manufacturer's instruction. In brief, co-detection and quantiﬁcation of
the three CyDye-labeled forms of each spot was performed using the Differential In-gel Analysis (DIA)
module, allowing the calculation of ratios between samples and internal standard abundances for
each spot. Matching of spots across all gels and correction of inter-gel variability through
normalization of the Cy2 internal standard spot maps present in each gel was realized by the
Biological Variance Analysis (BVA) module. Protein spots that showed a statistically signiﬁcant
Student's t-test (po0.05) for an average spot abundance change of at least 1.5 were subjected to
identiﬁcation by MALDI-TOF/TOF mass spectrometry.
1.5. In-gel digestion and mass spectrometry (MS) analysis
Preparative gels that contained 200–300 mg of either NA or TA protein samples and 25 mg of the
internal standard were run in parallel and matched to the analytical gels master image to generate
picking lists of differentially expressed spots used to drive automated gel plug collection by the Ettan
Spotpicker (GE Healthcare). The proteins in gel pieces were subsequently in gel digested as described
by Mathy and colleagues [5], according to Shevchenko and colleagues protocol [6]. The gel pieces were
sequentially washed 3 times with 25 mM NH4HCO3 and 100% acetonitrile (ACN) to remove excess of
detergent and buffer. After the last dehydration in ACN, piece of gels were rehydrated for 1 h at 4 1C
with 2 mL of 5 mg/mL trypsin proteomic grade solution (Roche) diluted in 25 mM NH4HCO3 in order to
ensure sufﬁcient trypsin diffusion and to prevent autocatalysis. Finally the temperature was increased
to 37 1C for an overnight digestion.
Peptides were extracted by adding 5 μL of a 1% triﬂuoroacetic acid (TFA) (v/v)/30% ACN (v/v)
solution and vortexing for 30 min. 2 μL of the resulting extract were deposited on a 384–600 MTP
Anchorchip MALDI target plate (Brüker Daltonic) previously spotted with a 30 mg/mL (w/v) of
α-cyano-4-hydroxycinnamic acid (CHCA) matrix solution (Sigma) diluted in acetone. After drop
drying, each spot was desalted with cold 10 mM ammonium phosphate solution. Samples were
analyzed with an UltraFlex II MALDI-TOF/TOF (Brüker Daltonics) by MS ﬁngerprint (spectra
acquisition mass range: 70–4240m/z). Peaks with the highest intensities obtained in TOF-MS mode
were subsequently analyzed by LIFT MS/MS (mass range 40–1100). Proteins identiﬁcations were
carried out with the biotools software (Brüker) using the Mascot search engine. The generated peak
lists were used for mascot searching (www.matrixscience.com) using the following parameters for
both PMF and MS/MS experiments: trypsin digestion, Cystein carbamidomethylation and Methione
oxidation as ﬁxed and variable modiﬁcations respectively; mass values determined in monoisotopic
mode with PMF experiments, the peptide charge state was set as þ1 and the mass range was 70–
4240m/z. For MS/MS experiments, the fragment mass tolerance was70.3 Da and the mass range was
0–1100m/z. Searching was done against three version of UniprotKB/SwissProt database. Database A
corresponds to version 57.1 (462764 sequences; 163773385 residues) released on April 2009 and
database B corresponds to version 57.7 (497293 sequences; 175274722 residues) released on
September 2009, database C corresponds to version 2014_05 (545388 sequences; 193948795
residues) released on May 2014.
1.6. Immunocytoﬂuorescence
One thousand NA and TA cells were seeded as 50 ml drops on glass coverslips coated with 100 mg/ml
polyornithine (Sigma) in MEMmedium containing 10% FCS for 48 h. The cells were maintained in serum-
free MEM medium for 24 h, rinsed twice in PBS, prior to be ﬁxed with 4% paraformaldehyde.
The ﬁxed cultures were washed 3 times in TBS buffer, permeabilized in 1% Triton-X100 (v/v) for
15 min and washed 3 times in TBS buffer. Non-speciﬁc binding was blocked using TBST containing
non-fat milk powder (30 mg/ml) for 45 min. The cells were then incubated overnight at 4 1C with the
following primary antibodies mixture diluted in blocking buffer: Anti-PK (Chemicon international,
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produced in rabbit, 1/500). After 3 TBST washes, cells were incubated with FITC or RRX conjugated
antibodies (Jackson Immunoresearch, Ref: 711-095-152 and 805-295-180, dilution 1:2500) for 1 h at
RT and in the dark. Nucleus staining was achieved with 40,6-diamidino-2-phenylindole (DAPI). The
preparations were examined using Olympus confocal (Leica).Appendix A. Supplementary material
Supplementary data associated with this article can be found in the online version at http://dx.doi.
org/10.1016/j.dib.2014.09.004.References
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